“Ambulance & Medical Transport Market Worth $32.11 Billion in 2019”, says Visiongain report

19 December 2019
Pharma

Visiongain’s new report the Ambulance & Medical Transport Market Report 2019-2029 : Forecasts by Type (Medical Products Transport, Mobile Treatment Facilities, Patient Transport, Incubator Transport), by End User (Hospitals, Nursing Care Facilities, Medical Centers, Private Paying Customers), plus analysis of leading companies indicates that the global Ambulance & Medical Transport market will attain $59 billion revenue by 2029.

Global Ambulance & Medical Transport market is expected to grow on account of increasing number of medical complication in the population. The market is expected to grow at a healthy CAGR of 6.3% over the projected period. Ambulance and medical transportation relates to medical equipment that promotes patient care during medical emergencies, such as accidents and surgery, helps avoid life loss, and minimizes personal injury. Technological progress, rising incidence of accidents, and growing population ageing are some of the primary factors driving the market for ambulance and medical transport.

Transport services in the healthcare industry act as an assistance to guarantee secure and timely transfer from one place to another of patients, medications, medical equipment and test specimens. This, in turn, improves the healthcare sector's effectiveness. The segment of patient transport is expected to account for most market share and is projected to develop at a greater pace driven by increasing emphasis on enhancing the value chain in the healthcare industry.

In 2019, North America accounted for more than 35% of overall ambulance and medical transport demand and increasing prevalence of chronic diseases, growing healthcare expenditure, and advanced healthcare infrastructure in this region is expected to strengthen Ambulance & Medical Transport market concentration in North America over the projected period. Asia Pacific region is anticipated to witness fastest growth rate in the ambulance and medical transportation industry in the coming years due to growing health infrastructure, increased accident prevalence, increased disposable income, increased incidence of multiple illnesses, increased elderly population, and increased awareness of emergency medical transportation services available on the market.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Viral Vectors & Plasmid DNA Manufacturing Market Report 2021-2031

Due to increases in the therapies in progress, the dosages provided, & the patient populations targeted, viral vector production capacity has become increasingly reduced in recent years. The condition is aggravated by COVID-19.

03 December 2020

Read

Visiongain Publishes Drugs of Abuse Testing Market Report 2021-2031

Drugs Abuse has risen very significantly in few last year as compared to previous once and expected to continuously rise over the forecast period. The increase in the drugs abuse creates a huge demand for the drugs of abuse testing products.

03 December 2020

Read

Visiongain Publishes Controlled Substance Market Report 2021-2031

Continuous increasing prevalence of chronic pain is increasing demand for controlled substance as treatment for Chronic pain. Due to which increasing prevalence of chronic pain around the world is working as a driver for the controlled substance market.

03 December 2020

Read

Visiongain Publishes Companion Animal Diagnostics Market Report 2021-2031

All regions are facing rapid growth in the companion animal population. Companion animal are at high risk of developing various diseases for which companion animal require timely diagnosis for the identification, detection and treatment for life causing diseases.

03 December 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever